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ABSTRACT 
Atrial fibrillation (AF) is a significant cause of cardioembolic strokes. AF is often symptomless and 
intermittent, making its detection challenging. The aim of this study was to assess the possibility to  
use a chest strap (Suunto Movesense) to detect AF both by cardiologists and automated algorithms. 
A single channel electrocardiogram (ECG) from a chest strap of 220 patients (107 AF and 111 sinus 
rhythm SR with 2 inconclusive rhythms) were analyzed by two cardiologists (Doc1, Doc2) and two 
different algorithms (COSEn, AFEvidence). A 3-lead Holter served as the gold standard ECG for 
rhythm analysis. Both cardiologists evaluated the quality of the chest strap ECG to be superior to 
the quality of the Holter ECG; p<0.05/p<0.001 (Doc1 / Doc 2). Accurate automated algorithm-
based AF detection was achieved with sensitivity of 95,3%/96.3% and specificity of 95,5/98.2% 
with two AF detection algorithms from chest strap and 93.5%/97.2 % and 98.2%/95.5% from 
Holter, respectively. P-waves were detectable in 93.7% (Doc1) and 94.6% (Doc2) of the cases from 
the chest strap ECG with sinus rhythm and 98.2% (Doc1) and 95.5% (Doc2) from the Holter 
(p=n.s).  In conclusion, the ECGs from both methods enabled AF detection by a cardiologist and by 
automated algorithms. Both methods studied enabled P-wave detection in sinus rhythm.  
Keywords: atrial fibrillation, atrial fibrillation screening, stroke
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 Cardioembolic stroke accounts for 20%-30% of ischaemic strokes
1, 2
, and atrial fibrillation 
(AF) is one of the most important causes of embolus of cardiac origin
2
. Furthermore, approximately 
25% of strokes are classified as cryptogenic, a major portion of these being classified as embolic 
stroke of undetermined source (ESUS) 
3, 4
. With proper anticoagulation therapy, up to two thirds of 
AF-related strokes can be prevented 
5, 6
. Finding the cause of stroke in order to start proper 
treatment remains a big clinical challenge. The gold standard for diagnosis of AF is by 12-lead 
electrocardiogram (ECG)
7
. Current screening methods for AF include pulse palpation 
8
,  handheld 
single-lead ECG-devices
9-11
, modified blood pressure monitors
12, 13
 and devices based on 
photoplethysmography (PPG) 
14-17
. Currently available consumer products have been studied in the 
feasibility and diagnosis accuracy of AF
18
, but there is still a need for ECG strip for the 
confirmation of AF diagnosis
7
.  On the other hand, chest strap heart rate (HR) monitors have been 
used for sports HR monitoring for decades and the technique is widely available. It is unknown 
whether ECG acquired using a chest strap could serve as a tool for arrhythmia detection. The aim of 
the study was to assess the potential of an ECG aquired using a chest strap to detect AF, both by 
cardiologists and automated algorithms. 
Methods 
The study design was a prospective case-control multicenter study at three sites in Finland. 
The study data was collected in emergency departments and cardiologic wards of the participating 
hospitals: Kuopio University Hospital, Helsinki University Central Hospital and North Karelia 
Central Hospital, Joensuu. The study design was approved by the Ethical Committee of Kuopio 
University Hospital (Decision number 237/2017) and registered in ClinicalTrials database 
(NCT03721601,URL: https://clinicaltrials.gov/ct2/show/NCT03721601). 
Screening of study participants was performed in the participating hospitals from admitted 
patients in May–September 2017. The inclusion criterion for the study was atrial fibrillation 
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confirmed by a doctor-interpreted 12-lead ECG, taken for medical reasons. Exclusion criteria were 
body mass index (BMI) over 33 kg/m
2
; implanted pacemaker device; left bundle branch block 
(LBBB) or right bundle branch block (RBBB); a medical condition requiring immediate treatment 
that would be delayed by the study measurements, and serious infectious disease. The control group 
consisted of patients with normal sinus rhythm in 12-lead ECG. Study participants gave a written 
informed consent.  
The study population consisted of 220 patients. According to the initial 12-lead ECG, a total 
of 110 patients with atrial fibrillation were collected, with the control group consisting of 110 
patients with normal sinus rhythm. The initial 12-lead ECG was only used in the recruitment 
process of patients. The 3-lead Holter ECG rhythm analysis was conducted by two experienced 
cardiologists blinded to the initial ECG. The cardiologists’ interpretation of the 3-lead Holter ECG 
rhythm was used as the gold standard for rhythm analysis. A flowchart is presented in Figure 1. 
First, a 12-lead ECG was recorded over a period of 10 seconds for rhythm confirmation, 
after which the ECG electrodes were removed. The 12-lead ECG was mostly recorded as a part of a 
routine medical examination and only in a few cases for study purposes only. The time gap between 
the 12-lead ECG and the study recording was not limited by the study protocol and ranged from a 
few minutes to several hours. Because of this, in some cases the rhythm of 12-lead ECG had 
changed from the original recorded rhythm (4 from AF to SR; 2 from SR to AF), and this in turn 
affected the number of AF/SR in final rhythm analysis (Figure 1). 
In the next step, 5 wet electrodes were attached to each patient to record ECG with a Faros 
360 Holter device (Bittium, Oulu, Finland; device 1, Figure 2) used as the gold standard for rhythm 
monitoring. Simultaneously a heart rate monitoring chest strap with ECG recording capability 
(Suunto Movesense, Suunto, Vantaa, Finland; device 2, Figure 2) was applied to the chest, 
approximately 2 cm below the lower end of the sternum, according to the manufacturer’s 
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instructions. A total of 5 min ECG recording was made. The measurement method/study design is 
presented in Figure 2. Examples of ECG strips acquired are presented in Figure 3. Standard 12 lead 
ECG and ECG morphology produced by the chest strap is presented in Supplementary Figure 1. 
The data from the heart rate monitor chest strap was sent via Bluetooth connection to a 
mobile phone, from which it was transferred via a USB cable to a PC computer. The data from the 
Faros Holter device was recorded to the device´s internal memory card and transferred to a PC 
equipped with analyzing software. The data collected was anonymized and ECG data from the chest 
strap and the Holter device were analyzed using an in house application developed by the authors. 
The ECGs acquired by the chest strap (1-lead) and the Holter (3-lead) were analyzed in a 
random order by two experienced cardiologists blinded to the initial 12-lead ECG. The quality of 
the ECG strip was defined as good (no or only minor artefacts), average (artefacts but QRS and/or 
P-wave identifiable) or poor (major artefacts, no identifiable QRS and/or P-wave) by the 
cardiologists. The rhythm of the ECG recordings was divided into three categories: sinus rhythm, 
atrial fibrillation or other/inconclusive. The cardiologists also assessed the possibility of detecting 
P-waves from the ECG strips with SR (yes/no). 
Two previously published AF detection algorithms were used in this study. Algorithms were 
used to demonstrate the possibilities of automatic screening of AF using the chest strap ECG 
devices with automated analysis. The first method used was AFEvidence proposed by Sarkar et al.
19
 
AFEvidence is based on a relative population of the segments in the ΔRR 2D histogram {ΔRR(i), 
ΔRR(i-1)}. The threshold for AF detection is AFEvidence>50. The second algorithm used in the 
study was COSEn proposed by Lake et al.
20
  COSEn is based on an optimized sample entropy 
estimate and the mean heart beat interval. The threshold for AF detection is COSEn>-1.6. 
The estimated sample size was 200 observations with assumed sensitivity of the method 
being 95% with 3% margin of error. The data were analyzed using IBM SPSS statistics software 
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version 23. Demographic variable data were presented as frequencies and percentages or mean and 
standard deviation (SD). Group differences were tested by t-test or chi-square test. McNemar-
Bowker test was used in testing the opinion between cardiologists, and the Kappa-coefficient was 
calculated to measure the level of consensus. In addition, sensitivity and specificity were 
determined between cardiologist consensus and algorithms. All significance tests were two-tailed 
with p≤ 0.05 considered statistically significant. 
Results 
According to the flowchart, with the 3-lead Holter ECG serving as the gold standard, a total 
of 218 patients were included in and 2 were excluded from the analysis (Figure 1). Two of the 220 
3-lead Holter ECGs could be classified neither as sinus rhythm nor atrial fibrillation, one in AF and 
one in SR group. One of them converted from atrial flutter to sinus rhythm during recording, and 
the quality of the other ECG was insufficient for rhythm analysis. These two Holter ECGs and the 
corresponding chest strap ECGs were excluded from the final analysis. 
Demographics of study participants, including age, gender, previous medical history (as 
reported by patient or from patient medical records), height, weight and BMI, were recorded (Table 
1). The patients in the AF group were older, had a faster heart rate, and more hypertension, 
congestive heart disease or previous heart surgery, compared to the SR group. 
The opinion of the quality of the ECGs differed significantly between cardiologists, both 
with the chest strap and the Holter ECGs, with a greater proportion classified as “good” with the 
chest strap ECG compared to the Holter ECG by both cardiologists. In patients with SR, P-waves 
were identifiable in majority of the ECG strips of chest strap and Holter ECGs, with no significant 
difference between the methods studied (Table 2).  
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The two algorithms used detected atrial fibrillation from the Holter and chest strap ECG 
with a good specificity and sensitivity. There was no significant difference in algorithm rhythm 
classification between the chest strap ECG and the Holter ECG (Table 3).  
Discussion 
The main finding of this study was that the quality of an ECG strip recorded from the chest 
strap was sufficient for reliable detection of AF both by cardiologists and by automated algorithms. 
Detection of asymptomatic arrhythmias for prevention and searching for the cause of stroke is a big 
clinical challenge. As of now, there are only a few methods available for clinical use, requiring 
expensive or invasive equipment and health-care professional interpretation of results. Novel 
methods for finding arrhythmias are needed. Currently, the use of ECG-based HR monitors is 
limited to heart rate monitoring in sports, and the already existing possibility of acquiring ECG strip 
is not currently used in search for arrhythmias. 
Screening for AF ranges from opportunistic pulse palpation during a routine check-up to 
invasive, prolonged monitoring in post-stroke studies. Non-invasive screening methods include 
pulse palpation or surface ECG and continuous hospital telemetry, ambulatory ECG (Holter), 
patient-triggered event recorder and prolonged ambulatory ECG (mobile cardiovascular telemetry). 
Invasive screening methods include implantable loop recorders and pacemakers with atrial leads 
and implantable cardioverter defibrillators (ICDs)
21
. A recent collaboration for screening for atrial 
fibrillation (AF-SCREEN) discusses in a white paper the advantage of handheld ECG devices in 
providing verifiable ECG traces for diagnosis of AF according to guidelines. Furthermore, for 
screening to be effective in preventing strokes, it must be linked to a pathway for diagnosing atrial 
fibrillation and initiation of anticoagulation
17
. Algorithm-based devices can be used for screening 
purposes, but an actual ECG-strip is needed for the diagnosis of AF. Current commercial devices in 
detecting AF include ECG-based devices
9-11
 and detection of AF by pulse irregularity using blood 
pressure monitors, mobile phone apps/cameras and wearable technology
12-16
. None of them are 
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currently able to provide an actual ECG-strip. Inexpensive consumer products have been studied for 
the screening of AF
18
. If these products are to be used in future for the diagnosis of atrial 
fibrillation, they need to be registered as medical devices with FDA approval (US) or CE mark 
(EU). 
The interest in self-monitoring is increasing. The number of devices providing information 
on one’s health is abundant and they are used by a large population of consumers. The theoretical 
possibility of AF detection is already built in with many of the commercial chest straps used for 
heart rate monitoring in sports, since many heart rate monitors such as chest straps use single-
channel ECG in HR measurement, detecting QRS complexes and measuring R-R intervals. The 
advantage of the method used in this study is the capability of some the commercially available HR 
monitor chest strap studied to produce and transmit ECG (Suunto Movesense), and this seems to be 
of a study intrerest of all the biggest heart rate monitor manufacturers. To the best of our 
knowledge, this is the first time when single-channel ECGs from a HR monitor chest strap has been 
used for detecting atrial fibrillation both by clinicians and automated algorithms, producing an ECG 
strip for clinician. In the SAFE study by Lown et al. 
18
, the screening of AF was performed by 
algorithm-only using four different devices. In our study, the diagnosis of two experienced 
cardiologists was compared with algorithm diagnosis yielding in good specificity and sensitivity for 
the method studied and, in addition, an ECG strip from chest strap with sufficient quality for the 
diagnosis of AF.   
There are some limitations in this study. First, some of the patients in the original AF group 
were in sinus rhythm in the final analysis. The minimum number of 100 patients per group was 
achieved by the collection of additional patients in each group. Second, the measurement using the 
chest strap was made in optimal conditions with a supine, resting patient and the chest strap 
application being made by the researcher. The measurement period was restricted to 5 minutes. In 
real-life measurements, the artefacts and poor signal quality resulting from, for example, movement, 
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inaccurate positioning of the chest strap, dryness of skin and electrodes, are sources of signal noise 
and decrease the accuracy for automated algorithms as well as the human eye in interpreting the 
ECG signal. Moreover, we did not collect patients from a specific age group. The incidence of AF 
increases in the elderly population, in which possible problems with cognition and ability to use 
new technologies can be decreased. Also, usability of the technology studied in obese patients 
cannot be concluded from our results, since the inclusion criterion was BMI less than 33. 
After clinical validation and studies for longer measurement times and moving subjects, the 
chest strap with the ECG sensor could be used both in opportunistic and systematic screening for 
atrial fibrillation. For asymptomatic risk group patients, chest strap ECG screening could be 
implemented. Furthermore, it could be used in long-term follow-up of post-stroke patients in 
finding AF. In both cases, chest strap ECGs would offer the ECG strip recommended by guidelines 
for confirmation of the diagnosis of AF. If our study technique with the use of the actual ECG 
acquired from the HR monitor chest strap appears to be practical and can be validated, it opens an 
opportunity for a low-cost screening method that is easy to implement in large populations at risk of 
AF and in post-stroke studies. 
The quality of the chest strap ECG was superior to the Holter ECG as analyzed by two 
experienced cardiologists. The ECG using the chest strap enables accurate detection of AF by using 
automated algorithms. P-wave was detected from chest strap ECG strips in patients with sinus 
rhythm in 93.7%/94.6% of cases. An ECG strip from chest strap offers a possibility for 
confirmation of AF diagnosis as suggested in present guidelines. ECG recording using the chest 
strap for the detection of AF in risk groups and in post-stroke screening seems promising but needs 
further studies in larger populations and in real-life situations in addition to encompassing longer 
measurement periods. In general, easy-to-use and low-cost solutions are needed in screening for 
arrhythmias such as AF, and the use of evolving mobile technology enables remote monitoring in 
the near future. 
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Figure legends 
 
Figure 1. Flowchart. AF=atrial fibrillation; ECG=electrocardiogram; SR=sinus rhythm; 
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Figure 2. Measurement of ECG with Suunto Movesense chest strap with ECG acquisition (2). As 
control, 3-lead Faros 360 Holter device using wet electrodes were used (1).  5 min measurement 
was done simultaneously using both devices with the study subject resting in supine position 
LA=left arm; LL=left limb; RA=right arm; V5=electrode positioned in position corresponding 
electrode V5 in 12 lead ECG. 
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Figure 3. Typical examples of ECG recording of sinus rhythm (SR) and atrial fibrillation (AF) 
using Faros 360 Holter ECG and Suunto Movesense chest strap. mV=millivolt 
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Table 1. Patient demographics 
 AF (N=107) SR (N=111) p 
Male/Female  58/42% 55/45% 0.68 
Age (years) 72±14 55 ±19 <0.0001 
Height (cm) 172±10 171±10 0.972 
Weight (kg) 75±13 74±12 0.848 
BMI (kg/m
2
) 25,2±3.0 25,3±3.1 0.324 
Mean HR (bpm) 94±22 68±13 <0.0001 
Coronary heart disease 27.1% 23.4% 0.5 
Diabetes mellitus 20.6% 13.3% 0.166 
Hypertension 61.7% 44.1% <0.01 
Congestive heart disease  19.6% 2.7% <0.0001 
Previous heart surgery* 13.1% 4.5% <0.05 
AF=atrial fibrillation; BMI=body mass index; HR=heart rate; SR=sinus rhythm 
*Heart surgery type not specified 
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Table 2: Visual quality and and P-wave visibility of Holter and chest strap 
recordings.  
Quality* (N=218) Holter 
(Doc 1 / Doc 2) 
Chest strap                   
(Doc 1 / Doc 2) 
good 
average 
poor 
71.6 %/ 85.3% 
17.0% / 12.4% 
6.9% / 2.3% 
83.0% / 95.9% 
15.1% / 4.1% 
1.8% / 0.0% 
P-waves visible** 
  
SR (N = 111) 
AF (N=107) 
98.2% / 95.5% 
0 / 0 
93.7% / 94.6% 
0.9 / 0.9 
*Quality of chest strap ECG is better than Holter ECG; p<0.05/p<0.001 (Doc1 / Doc 2) 
**P-wave visibility is better in Holter than chest strap ECG; p=n.s /p=n.s (Doc1 / Doc 2) 
AF=atrial fibrillation; ECG=electrocardiogram; SR=sinus rhythm 
 
 
 
Table 3: Sensitivity and specificity of AFEvidence and COSEn methods to detect 
AF from Holter and chest strap ECG recordings.  
  Specificity Sensitivity 
Holter AFEvidence 
COSEn 
98.2% 
95.5% 
93.5% 
97.2% 
Chest strap AFEvidence 95.5% 95.3% 
 COSEn 98.2% 96.3% 
*Algorithms can classify rhythm better from Holter than from chest strap ECG; p=n.s /p=n.s 
ECG=electrocardiogram 
  
